mRNA

Federal COVID-19 vaccine contracts mean Canada should get enough doses to give two or three more mRNA shots to every Canadian, every year until at least 2024.

It's pronounced koh-MIHR'-nuh-tee. Never heard of it? Well, get used to it. It's what Canada will be calling the Pfizer vaccine from now on, at least officially.

U.S. drug maker Moderna will sign an agreement with the Canadian government today, August 10, 2021, promising to build an mRNA production plant in Canada.

Health Canada's latest weekly report on vaccinations shows at least 1.3 million Canadians opted for a mixed-dose finish to their COVID-19 vaccination schedule in June.

A vaccine study in the United Kingdom reports that getting a dose of the Pfizer-BioNTech vaccine four weeks after a dose of Oxford-AstraZeneca produced a much stronger immune response than two doses of AstraZeneca.

As scientific and medical discourse plays out in real time online and in the media during the COVID-19 pandemic, observers specializing in science and risk communication say Canadians must be even more discerning in choosing which expert voices they listen to and amplify.

A single dose of Pfizer-BioNTech's COVID-19 vaccine is barely enough to cover the average pinky nail but is made up of more than 280 components and requires at least three manufacturing plants to produce.

Canada is home to significant scientific expertise and research tackling COVID-19, though one expert says long-standing hurdles make it difficult for the country to punch above its weight in the global fight against the virus.

It was near the end of June that Dr. Vivek Goel decided to give up his job as vice-president research at the University of Toronto to make whatever contribution he could as a public health physician.

The head of a Canadian biotech industry association says Canada can and does make vaccines — just not the ones expected first to help stop the COVID-19 pandemic.